Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
Patients using diabetes apps can miss critical alerts. Here’s how to make sure you're getting them
Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback